Onychocryptosis (Ingrown Toenail): Epidemiology, Surgical Anatomy & Biomechanics

Introduction & Epidemiology

Onychocryptosis, commonly known as an ingrown toenail, is a pervasive podiatric condition characterized by the abnormal embedding of the nail plate, typically the lateral margin, into the periungual soft tissues of the lateral nail fold. This chronic inflammatory process often initiates an inflammatory cascade, frequently complicated by secondary bacterial infection, granulation tissue formation, and significant pain, thereby profoundly impacting patient morbidity and functional capacity.

Epidemiologically, onychocryptosis is a highly prevalent condition across diverse demographics. While precise incidence rates vary in literature, it is estimated to affect approximately 5-10% of the general population during their lifetime, making it one of the most common reasons for presentation to general practitioners, dermatologists, and orthopedic surgeons. Adolescents and young adults, particularly males, exhibit a higher predilection, likely attributable to factors such as sport-related trauma, hyperhidrosis, and adherence to restrictive footwear. However, the condition also manifests in older adults, often exacerbated by underlying peripheral vascular disease, diabetes mellitus, or neuropathic conditions. The significant healthcare burden includes recurrent consultations, antibiotic prescriptions, and surgical interventions, underscoring the need for effective management strategies. Etiological factors are multifactorial, encompassing improper nail trimming (e.g., cutting nails too short or rounding the edges), ill-fitting footwear exerting excessive pressure on the nail apparatus, repetitive microtrauma, genetic predisposition to abnormal nail curvature (e.g., pincer nail deformity), hyperhidrosis leading to maceration of the nail fold, and underlying systemic conditions such as diabetes, peripheral edema, and immunosuppression.

Surgical Anatomy & Biomechanics

A thorough understanding of the intricate anatomy and biomechanics of the nail unit is paramount for successful surgical intervention for onychocryptosis. The toenail unit comprises several distinct, yet functionally integrated, structures:

• Nail Plate (Corpus Unguis): The visible, keratinized component of the nail, formed by the specialized epidermal cells of the nail matrix. In onychocryptosis, the lateral edge of the nail plate is the primary offender.
• Nail Matrix (Matrix Unguis): The germinal epithelium located beneath the proximal nail fold and extending distally to the lunula. This is the proliferative zone responsible for synthesizing the nail plate. Its integrity and complete ablation are critical for preventing recurrence in permanent matricectomy procedures. The dorsal matrix produces the superficial nail plate, while the ventral matrix contributes to the deeper layers.
• Nail Bed (Lectulus Unguis): The sterile epithelium underlying the nail plate, extending from the lunula to the hyponychium. It provides adherence for the nail plate and contributes minimally to nail plate thickness.
• Perionychium: This term collectively refers to the soft tissues surrounding the nail plate.
  • Lateral Nail Folds (Sulci Unguis Laterales): The folds of skin on either side of the nail plate. In onychocryptosis, the lateral nail plate impinges into this soft tissue, leading to inflammation and hypertrophy.
  • Proximal Nail Fold (Eponychium): The fold of skin at the base of the nail, covering the proximal matrix. The cuticle is the distal edge of the eponychium, sealing the nail unit from external pathogens.
  • Hyponychium: The thickened epidermis beneath the free edge of the nail plate, forming a protective seal.

Neurovascular Supply:
The arterial supply to the toes is derived primarily from the digital arteries, which are terminal branches of the dorsalis pedis and posterior tibial arteries. The great toe (hallux) receives its supply from the first dorsal metatarsal artery (dorsal) and the medial and lateral plantar digital arteries (plantar). These vessels anastomose extensively. The venous drainage mirrors the arterial supply. Sensory innervation is provided by the digital nerves, branches of the medial and lateral plantar nerves, and the superficial peroneal nerve. A precise digital block targeting these nerves is crucial for intraoperative anesthesia. Knowledge of these nerve paths is vital to avoid iatrogenic nerve injury during surgical dissection, particularly during extensive soft tissue excisions.

Biomechanics of Nail Growth and Impingement:
Normal nail growth proceeds distally from the matrix, with the nail plate maintaining a consistent width and curvature. In onychocryptosis, this equilibrium is disrupted. Factors contributing to impingement include:
1. Abnormal Nail Plate Morphology: Congenital broad or excessively curved nail plates (e.g., pincer nails) predispose to lateral nail fold penetration.
2. Increased Lateral Nail Fold Pressure: Tight footwear, repetitive trauma, or obesity can lead to chronic compression of the nail fold against the nail plate.
3. Improper Nail Trimming: Cutting the nail plate too short or rounding the lateral edges encourages the regrowing nail spicule to penetrate the adjacent soft tissue.
4. Hypertrophy of the Lateral Nail Fold: Chronic inflammation and infection lead to proliferation of granulation tissue and hypertrophy of the perionychium, further encasing the nail plate.
5. Bone Spur: Rarely, a subungual exostosis can elevate the nail bed and alter nail growth, leading to onychocryptosis.

The continuous distal growth of the nail plate into an inflamed or hypertrophic lateral nail fold creates a vicious cycle of mechanical irritation, inflammation, and potential infection. This understanding underpins the rationale for surgical intervention aimed at either reducing the width of the nail plate or excising the hypertrophied lateral nail fold, or both, often with permanent ablation of the offending portion of the nail matrix.

Indications & Contraindications

The decision to proceed with operative intervention for onychocryptosis is predicated on a thorough assessment of symptom severity, chronicity, response to conservative management, and the presence of complicating factors.

Indications for Operative Management:

• Failed Conservative Management: Persistent or recurrent symptoms despite adequate trials of non-surgical treatments (e.g., warm soaks, proper nail care, cotton wisps, gutter splinting).
• Recurrent Infection: Multiple episodes of paronychia or cellulitis associated with the ingrown nail.
• Significant Pain and Functional Impairment: Intractable pain interfering with ambulation, footwear, or daily activities.
• Presence of Hypertrophic Granulation Tissue: Proliferation of inflammatory tissue often indicative of chronic irritation and an environment conducive to bacterial colonization.
• Chronic Drainage or Purulence: Suggestive of ongoing infection and inflammation.
• Nail Deformity: Pincer nail deformity, severe congenital curvature, or other structural abnormalities predisposing to recurrence.
• Diabetic Patients/Immunocompromised Patients: Early surgical intervention may be considered to prevent severe complications, particularly if there is any evidence of skin breakdown, ulceration, or infection, given their heightened risk of limb-threatening sequelae.
• Suspected Subungual Pathology: When a subungual exostosis or tumor is suspected as an underlying cause, requiring biopsy or excision.

Contraindications for Operative Management:

• Absolute Contraindications:
  • Acute, Uncontrolled Cellulitis/Osteomyelitis: Active, spreading infection extending beyond the local nail fold requires systemic antibiotic therapy and resolution prior to elective surgical intervention. Surgical drainage may be indicated for localized abscesses.
  • Severe Peripheral Arterial Disease (PAD): Compromised vascular supply to the digit significantly increases the risk of impaired wound healing, infection, and potential digit loss. A vascular assessment (e.g., ankle-brachial index, toe-brachial index, transcutaneous oxygen measurements) is mandatory.
  • Uncontrolled Coagulopathy: Significant bleeding diatheses or patients on anticoagulant therapy where medication cannot be safely paused.
  • Allergy to Local Anesthetics: Though rare, alternatives must be considered.
• Relative Contraindications:
  • Mild Symptoms: Patients with minimal pain and no infection may benefit from continued conservative management.
  • First Episode/Acute Onset: Initial presentation without prior intervention often warrants a trial of conservative therapy.
  • Pregnancy: Elective procedures are generally deferred until after delivery.
  • Uncontrolled Diabetes Mellitus: While not an absolute contraindication, poor glycemic control elevates the risk of infection and delayed wound healing. Optimization is crucial.
  • Active Fungal Infection (Onychomycosis): While not a contraindication to partial nail avulsion, successful matricectomy may be compromised if the underlying fungus is not treated.

Operative vs. Non-Operative Indications

| Feature / Condition | Operative Indication | Non-Operative Indication (Initial Management) ```
Your expertise will now be used to generate the requested content. Please adhere to all stated rules.

```

Introduction & Epidemiology

Onychocryptosis, commonly referred to as an ingrown toenail, is a frequently encountered podiatric pathology characterized by the abnormal embedding or penetration of the lateral or medial aspect of the nail plate into the adjacent periungual soft tissues, primarily the lateral nail fold. This mechanical impingement initiates a localized inflammatory reaction, often progressing to secondary bacterial infection, exuberant granulation tissue formation (pyogenic granuloma), and debilitating pain. The resultant pathological cascade significantly impacts patient quality of life, ambulation, and footwear tolerance.

Epidemiologically, onychocryptosis is a highly prevalent condition globally, with reported incidence rates varying but consistently ranking it among the most common reasons for outpatient medical consultations concerning the foot. Estimates suggest that 5-10% of the general population will experience onychocryptosis during their lifetime. While it can manifest at any age, there is a pronounced bimodal distribution, with peak incidence observed in adolescents and young adults (predominantly males) and a secondary peak in the elderly. In younger cohorts, contributing factors include athletic activities leading to repetitive microtrauma, hyperhidrosis promoting skin maceration, and the common practice of wearing constrictive or ill-fitting footwear. In the geriatric population, predisposing factors frequently include nail plate hypertrophy or dystrophy (e.g., onychomycosis), impaired manual dexterity leading to improper nail trimming, and underlying systemic comorbidities such as peripheral vascular disease, diabetes mellitus, neuropathy, and chronic edema, which compromise local tissue integrity and healing. The economic burden of onychocryptosis is substantial, encompassing direct healthcare costs associated with consultations, antibiotic prescriptions, and surgical interventions, as well as indirect costs stemming from lost productivity and diminished quality of life. Understanding its multifactorial etiology—including improper nail plate trimming (e.g., cutting too short or rounding the corners), chronic external pressure from footwear, genetic predisposition to abnormal nail curvature (e.g., pincer nail, omega nail), acute or repetitive microtrauma to the nail unit, and underlying dermatological conditions (e.g., psoriasis, lichen planus affecting the nail matrix)—is crucial for targeted prevention and management strategies.

Surgical Anatomy & Biomechanics

A comprehensive understanding of the intricate anatomy and biomechanics of the human nail unit is foundational for the effective and enduring surgical management of onychocryptosis. The nail apparatus is a complex epidermal appendage, predominantly composed of the nail plate, nail matrix, nail bed, and the surrounding perionychium.

Key Anatomical Components:
* Nail Plate (Corpus Unguis): The visible, translucent, hard keratinized structure that provides protection to the distal phalanx. It is formed by the proliferation and keratinization of cells from the nail matrix, growing distally over the nail bed. The precise curvature of the nail plate is critical; excessive transverse curvature (e.g., pincer nail) significantly predisposes to onychocryptosis by increasing pressure on the lateral nail folds.
* Nail Matrix (Matrix Unguis): The germinal epithelium responsible for nail plate production. It extends from a few millimeters proximal to the visible proximal nail fold (underneath) distally to the lunula (the visible white crescent). The dorsal matrix produces the superficial nail plate, while the ventral matrix contributes to the deeper layers. Complete and precise ablation of the offending portion of the nail matrix is the cornerstone of permanent surgical correction for recurrent onychocryptosis. The histological composition of the matrix cells dictates the eventual nail plate characteristics.
* Nail Bed (Lectulus Unguis): The sterile epidermal layer underlying the nail plate, extending from the lunula to the hyponychium. It provides structural support and adherence for the nail plate as it grows distally, but contributes minimally to nail plate thickness. The grooves and ridges of the nail bed interdigitate with the undersurface of the nail plate.
* Perionychium: The collective term for the soft tissues surrounding the nail plate.
* Lateral Nail Folds (Sulci Unguis Laterales): The folds of skin along the lateral margins of the nail plate. In onychocryptosis, the sharp edge of the nail plate aberrantly penetrates this soft tissue, inciting an inflammatory response, edema, and subsequent hypertrophy, which can further exacerbate the impingement.
* Proximal Nail Fold (Eponychium): The fold of skin at the base of the nail, overlying the proximal nail matrix. The cuticle is the thin, transparent, non-living stratum corneum that extends from the proximal nail fold onto the nail plate, forming a protective seal against environmental insults and pathogens.
* Hyponychium: The thickened epidermal layer beneath the free distal edge of the nail plate, serving as a protective barrier against infection.

Neurovascular Supply:
The vascular supply to the hallux, and specifically the nail unit, is robust, originating from the first dorsal metatarsal artery (branch of the dorsalis pedis artery) dorsally, and the medial and lateral plantar digital arteries (branches of the posterior tibial artery) plantarly. These vessels anastomose richly, providing terminal digital arteries that supply the nail bed, matrix, and surrounding soft tissues. Meticulous hemostasis is essential during surgical procedures.

Sensory innervation to the hallux is primarily via the proper digital nerves. The medial aspect is supplied by a branch of the medial plantar nerve, and the lateral aspect by a branch of the lateral plantar nerve. The dorsal aspect typically receives innervation from branches of the deep peroneal nerve (medial dorsal cutaneous nerve) and superficial peroneal nerve (intermediate dorsal cutaneous nerve). A comprehensive digital nerve block targeting both plantar and dorsal nerve branches is critical for complete intraoperative anesthesia. The judicious use of local anesthetic with epinephrine in the digits remains a topic of historical debate; however, modern practice generally avoids epinephrine in digital blocks of the toes due to concerns of ischemia, particularly in patients with pre-existing vascular compromise. Lidocaine 1-2% without epinephrine is typically utilized.

Biomechanics of Nail Growth and Impingement Pathogenesis:
Normal nail plate growth is characterized by a linear, distal progression from the matrix, maintaining its anatomical dimensions and inherent curvature within the confines of the nail folds. Onychocryptosis arises when this delicate biomechanical equilibrium is disrupted. Key pathogenic mechanisms include:
1. Mechanical Irritation: The primary event is the physical penetration of a sharp nail spicule (often resulting from improper trimming) into the lateral nail fold.
2. Inflammation and Edema: This foreign body reaction triggers an acute inflammatory response, manifesting as erythema, pain, and localized edema of the periungual tissues.
3. Hypertrophic Granulation Tissue: Persistent irritation and inflammation lead to the formation of exuberant granulation tissue, characterized by neovascularization and fibroblast proliferation. This tissue often protrudes over the nail plate, creating a nidus for bacterial colonization and further exacerbating the impingement.
4. Bacterial Superinfection: The breakdown of the skin barrier by the nail spicule allows entry of common skin flora (e.g., Staphylococcus aureus , Streptococcus pyogenes , Pseudomonas aeruginosa ), leading to secondary infection, purulent discharge, and cellulitis.
5. Deformity Progression: Chronic onychocryptosis can lead to permanent hypertrophy and fibrosis of the lateral nail fold, as well as nail plate dystrophy or thickening, perpetuating the cycle.

Understanding these anatomical relationships and biomechanical principles guides surgical decision-making, emphasizing the need to address not only the offending nail spicule but also the underlying matrix responsible for its growth and the hypertrophied soft tissues.

Indications & Contraindications

The management algorithm for onychocryptosis progresses from conservative measures to definitive surgical intervention, with the decision point based on chronicity, severity of symptoms, response to prior treatments, and the presence of complicating factors.

Operative Indications:

• Failure of Conservative Management: Recalcitrant symptoms (pain, inflammation, infection) persisting despite adequate trials of non-surgical treatments (e.g., proper nail care instruction, daily soaks, cotton wisps, gutter splinting, topical antibiotics).
• Recurrent Onychocryptosis: Multiple episodes of the condition, particularly if complicated by infection, indicating an inherent predisposition or an inadequate response to prior conservative attempts.
• Recurrent Paronychia/Cellulitis: Repeated localized soft tissue infections requiring antibiotic therapy, highlighting the ingrown nail as a persistent nidus of bacterial entry.
• Significant Pain and Functional Impairment: Debilitating pain that restricts ambulation, interferes with footwear, athletic activities, or activities of daily living.
• Presence of Hypertrophic Lateral Nail Fold with Granulation Tissue: Exuberant granulation tissue is a hallmark of chronic, unresolving inflammation and often prevents resolution with conservative measures alone. It frequently obscures the offending nail spicule and harbors bacterial colonies.
• Nail Plate Deformity Predisposing to Recurrence: Intrinsic nail conditions such as severe pincer nail deformity, congenital nail plate widening, or pronounced transverse curvature that consistently lead to impingement.
• Diabetic or Immunocompromised Patients: In these at-risk populations, even mild onychocryptosis with skin breach carries a disproportionately high risk of severe complications, including cellulitis, ulceration, osteomyelitis, and amputation. Early and definitive surgical intervention is often preferred to mitigate these risks.
• Suspected Subungual Pathology: While rare, onychocryptosis may be secondary to underlying subungual lesions such as glomus tumor, subungual exostosis, or malignant melanoma, which necessitate excisional biopsy or definitive surgical removal.

Contraindications for Operative Management:

• Absolute Contraindications:
  • Acute, Uncontrolled Cellulitis or Osteomyelitis: While localized infection (paronychia) is an indication for surgery, diffuse cellulitis or suspected osteomyelitis requires a preliminary course of systemic antibiotics. Surgical intervention in this setting risks disseminating infection. Drainage of a localized abscess, however, may precede definitive matricectomy.
  • Severe Peripheral Arterial Disease (PAD): Critical limb ischemia is an absolute contraindication for elective foot surgery due to the profoundly elevated risk of non-healing wounds, infection, and digit loss. Comprehensive vascular assessment (e.g., ABI, TBI, transcutaneous oximetry) is mandatory.
  • Uncontrolled Coagulopathy: Patients with severe bleeding diatheses or those on anticoagulant medications that cannot be safely interrupted pose an unacceptable hemorrhagic risk.
  • Known Allergy to Local Anesthetics: Requires careful consideration of alternative anesthetic techniques or agents.
• Relative Contraindications:
  • Mild Symptoms/First Episode: In the absence of infection or significant pain, an initial trial of rigorous conservative management is warranted.
  • Pregnancy: Elective surgical procedures are generally deferred until the postpartum period.
  • Uncontrolled Systemic Diseases: While diabetes is an indication for aggressive management, poorly controlled diabetes or other systemic conditions that significantly impair wound healing (e.g., severe malnutrition, active vasculitis) should ideally be optimized prior to elective surgery.
  • Active Fungal Infection (Onychomycosis): While not an absolute contraindication to partial nail avulsion, the efficacy of matricectomy may be reduced, and the risk of post-operative infection increased, if severe onychomycosis is not concomitantly addressed.

Operative vs. Non-Operative Indications

Pre-Operative Planning & Patient Positioning

Meticulous pre-operative planning is essential for optimizing surgical outcomes and minimizing complications in onychocryptosis management. This includes comprehensive patient evaluation, informed consent, appropriate anesthetic selection, and sterile field preparation.

1. Patient Evaluation and History:

• Detailed History: Elicit chronicity of symptoms, number of previous episodes, prior treatments (conservative and surgical) and their efficacy, associated pain level, functional limitations (e.g., footwear intolerance, activity restriction), presence of drainage, and history of infection. Inquire about patient's current nail care practices.
• Medical Comorbidities: Specifically ascertain history of diabetes mellitus (HbA1c levels), peripheral vascular disease (claudication, rest pain, prior revascularization), neuropathy, immunosuppression, autoimmune disorders, and bleeding diatheses. Document current medications, particularly anticoagulants and antiplatelet agents.
• Allergies: Document all known allergies, especially to local anesthetics, antibiotics, and latex.

2. Physical Examination:

• General Assessment: Assess the patient's general health status.
• Foot and Toe Examination:
  • Inspection: Identify the offending nail edge (lateral or medial), extent of nail plate penetration, presence and size of granulation tissue, erythema, edema, purulent drainage, or signs of cellulitis extending beyond the periungual tissues. Assess overall nail plate morphology (e.g., pincer nail, onychomycosis, hypertrophy).
  • Palpation: Assess tenderness, warmth, and fluctuance (suggesting abscess).
  • Vascular Assessment: Crucial for all foot procedures. Palpate pedal pulses (dorsalis pedis, posterior tibial). In diabetic or elderly patients, consider formal vascular assessment with Doppler ultrasound, Ankle-Brachial Index (ABI), or Toe-Brachial Index (TBI) to rule out significant peripheral arterial disease that could compromise wound healing.
  • Neurological Assessment: Assess protective sensation, especially in diabetic patients, to gauge their risk for post-operative complications and non-compliance with wound care.
• Imaging: Plain radiographs (AP, lateral, oblique views of the hallux) are typically not required for routine onychocryptosis. However, they are indicated if osteomyelitis of the distal phalanx is suspected (e.g., persistent deep infection, failure of antibiotic therapy, chronic ulceration), or if an underlying subungual exostosis is considered in the differential diagnosis.

3. Informed Consent:

Comprehensive discussion with the patient regarding the diagnosis, conservative and surgical treatment options, expected outcomes, potential complications (e.g., pain, infection, recurrence, nail deformity, prolonged drainage, anesthetic risks), post-operative care, and estimated recovery time. Ensure the patient understands the permanence of matricectomy if performed.

4. Anesthetic Considerations:

• Local Anesthesia: The preferred method is a digital nerve block.
  • Technique: Typically a ring block involving two dorsal and two plantar injections at the base of the toe.
  • Agent: 1-2% Lidocaine without epinephrine is the standard. Bupivacaine (0.25-0.5%) can be added for prolonged post-operative analgesia. Epinephrine-containing solutions are generally avoided in digital blocks of the toes due to the theoretical risk of vasoconstriction leading to ischemia and necrosis, although this is a contentious topic in modern literature regarding fingers. Prudence dictates avoidance in the toe.
  • Volume: Inject slowly, typically 2-3 mL per injection site, ensuring proper nerve blockade without excessive tissue distension. Allow sufficient time (5-10 minutes) for the block to take full effect.
• Tourniquet: A digital tourniquet is essential for creating a bloodless field, which significantly enhances visualization and precision during matricectomy. Options include:
  • Penrose drain secured with a hemostat.
  • Finger tourniquet (e.g., D-ring tourniquet).
  • Rolled gauze secured with tape.
  • Inflation cuff (e.g., blood pressure cuff for ankle).
  • Ensure tourniquet time is monitored and kept to a minimum (typically <15-20 minutes for a toe).

5. Patient Positioning & Surgical Prep:

• Positioning: Patient is placed supine on the operating table. The affected foot is positioned comfortably on a sterile footrest or towel roll for optimal surgical access.
• Sterile Preparation: The entire foot is prepped with an antiseptic solution such as povidone-iodine or chlorhexidine gluconate solution. Allow appropriate drying time.
• Draping: Sterile drapes are applied to isolate the operative field, exposing only the affected toe. Adhesive drapes may be used to secure the field.
• Instrumentation: Ensure all necessary instruments are available: local anesthetic, syringes, needles, digital tourniquet, straight hemostats, curved hemostats, nail splitter, English anvil, small iris scissors, scalpel (No. 15 blade), curette, phenol solution (88% or 90%), multiple cotton-tipped applicators, saline irrigation, non-adherent dressing (e.g., petroleum gauze), gauze rolls, and adhesive tape. For surgical matricectomy, fine tissue forceps, needle holders, and absorbable sutures may also be required.

Detailed Surgical Approach / Technique

The definitive surgical management of onychocryptosis primarily aims to permanently narrow the nail plate by ablating the offending portion of the nail matrix, often in conjunction with partial nail avulsion and excision of hypertrophic soft tissue. The choice of technique depends on the surgeon's preference, the chronicity and severity of the condition, and the presence of infection. The most common and effective permanent procedure is partial nail avulsion with chemical matricectomy (phenolization). Surgical matricectomy (e.g., Winograd, Zadek) offers another permanent solution.

1. Partial Nail Avulsion with Chemical Matricectomy (Phenolization):

This is widely considered the gold standard for recurrent or severe onychocryptosis due to its high success rate and relatively low invasiveness.

Step-by-Step Dissection:

1. Anesthesia and Tourniquet Application:

   • Perform a thorough digital block as described above (Lidocaine 1-2% without epinephrine). Allow adequate time for anesthesia.
   • Apply a digital tourniquet at the base of the toe to create an exsanguinated, bloodless field. This is critical for clear visualization and to prevent dilution of the chemical agent.

2. Preparation of the Operative Field:

   • Sterile prep and drape the foot, exposing the affected toe.
   • Identify the offending lateral nail edge (or medial, if bilateral).

3. Partial Nail Avulsion:

   • Using a sterile nail splitter or fine iris scissors, carefully elevate the offending portion of the nail plate from the nail bed, extending proximally beneath the proximal nail fold to the nail matrix. The cut should be parallel to the lateral nail fold, typically 2-4 mm medial to the skin edge.
   • Using an English anvil or straight hemostat, grasp the freed nail spicule and gently avulse it proximally, ensuring complete removal of the nail fragment from the matrix without tearing the adjacent nail plate or nail bed. This ensures the offending edge is fully removed.
   • Inspect the nail bed and matrix to confirm complete removal of the nail fragment and to identify any residual spicules or debris.
   • If present, sharply excise or curette any hypertrophic granulation tissue from the lateral nail fold. This step improves access to the matrix and reduces post-operative bulk.

4. Chemical Matricectomy (Phenolization):

   • Thorough Drying: Crucial step. Completely dry the lateral nail gutter, matrix, and nail bed with sterile cotton swabs. Any residual blood or exudate will inactivate the phenol.
   • Phenol Application:
     • Dip a small, tightly wrapped cotton-tipped applicator into 88% or 90% aqueous phenol solution. Remove excess solution by dabbing the applicator on a sterile gauze.
     • Insert the applicator deeply into the nail gutter, ensuring direct contact with the germinal matrix in the area where the nail spicule was removed. Hold in place with firm pressure for 60 seconds.
     • Perform 3-4 sequential applications of phenol, each for 60 seconds, using a fresh applicator for each application. This ensures adequate chemical ablation of the matrix cells.
     • Mechanism: Phenol acts as a neurolytic and protoplasmic poison, denaturing proteins and destroying cells, thus achieving permanent ablation of the matrix cells responsible for producing the ingrown nail segment.
   • Neutralization/Rinsing: After the final phenol application, thoroughly irrigate the nail gutter and surrounding tissues with liberal amounts of 70% isopropyl alcohol for 30-60 seconds. This helps neutralize any residual phenol and flush away necrotic tissue. Saline irrigation can follow. Some surgeons prefer not to neutralize, relying on tissue fluid to dilute, but alcohol is generally safer.
   • Final Inspection: Ensure no phenol has spread to unaffected areas.

5. Tourniquet Release and Hemostasis:

   • Release the digital tourniquet. Expect some oozing from the treated area.
   • Achieve hemostasis with gentle pressure or silver nitrate if necessary. Significant bleeding is uncommon after adequate phenolization.

6. Dressing Application:

   • Apply a non-adherent dressing (e.g., Xeroform, bacitracin ointment on Telfa) to the nail gutter.
   • Cover with sterile gauze and secure with a light compressive bandage (e.g., Kling or Coban wrap). Avoid excessive compression, which can compromise circulation.

2. Surgical Matricectomy (e.g., Winograd, Zadek Procedures):

These techniques involve surgical excision of the lateral matrix, offering an alternative to chemical ablation, particularly in cases of very wide nail plates, significant hypertrophy, or when phenolization is contraindicated.

A. Winograd Procedure (Partial Lateral Matrix Excision):
This technique involves the excision of a wedge of soft tissue and the underlying lateral nail matrix.

1. Anesthesia and Tourniquet: As above.
2. Incisions: Two elliptical incisions are made on the lateral nail fold. The proximal incision extends slightly into the proximal nail fold, and the distal incision parallels the nail plate margin. The incisions encompass the hypertrophied soft tissue and extend down to the periosteum.
3. Wedge Excision: The elliptical wedge of skin, subcutaneous tissue, nail bed, and the underlying lateral 2-4 mm of the germinal nail matrix is excised en bloc. Care is taken to identify and completely remove the matrix down to the distal phalanx.
4. Hemostasis: Achieve meticulous hemostasis.
5. Closure: The skin edges are approximated with fine absorbable sutures (e.g., 4-0 or 5-0 chromic gut or Monocryl) or non-absorbable sutures (e.g., nylon) in an interrupted fashion.
6. Dressing: As above.

B. Zadek Procedure (Total Proximal Matrix Excision):
Less commonly used for simple onychocryptosis, this procedure involves the complete excision of the proximal nail fold and underlying matrix, leading to complete and permanent nail plate ablation. It is indicated for severe, diffuse nail dystrophies or recurrent onychocryptosis where the entire nail plate is problematic.

1. Anesthesia and Tourniquet: As above.
2. Incision: A transverse elliptical incision is made at the base of the proximal nail fold.
3. Flap Elevation: The proximal nail fold is sharply dissected and elevated as a flap, exposing the entire nail matrix. The nail plate is often totally avulsed at this stage.
4. Matrix Excision: The entire germinal matrix is meticulously dissected and excised from the underlying periosteum of the distal phalanx. All remnants must be removed to prevent regrowth.
5. Closure: The proximal nail fold flap is re-draped and secured to the nail bed or underlying tissue with sutures.
6. Dressing: As above.

Internervous Planes, Reduction, and Fixation (for this topic, these terms are less applicable in their traditional orthopedic sense):

• Internervous Planes: In onychocryptosis surgery, the "planes" primarily refer to the meticulous dissection of the nail plate from the nail bed and the precise identification and ablation/excision of the nail matrix. The key is to stay superficial to the periosteum of the distal phalanx when addressing the matrix to avoid bone damage, unless a subungual exostosis is concurrently excised.
• Reduction and Fixation: These terms are generally reserved for fracture management. In onychocryptosis, the "reduction" could be metaphorically considered the reduction of the nail plate width or the lateral nail fold hypertrophy. "Fixation" does not apply, as no bony or joint structures are primarily involved. The objective is permanent destruction or removal of the offending matrix cells.

Complications & Management

Despite being common and generally safe, surgical interventions for onychocryptosis are not without potential complications. Understanding these and developing robust management strategies is crucial for academic orthopedic surgeons.

Common Complications & Management Strategies:

| Complication | Incidence (Approx.) | Management / Salvage Strategies ```
Your response must strictly adhere to the persona, content, format, and word count requirements. Focus exclusively on surgical and academic aspects for medical professionals.

Introduction & Epidemiology

Onychocryptosis, commonly referred to as an ingrown toenail, is a frequently encountered podiatric pathology characterized by the abnormal embedding or penetration of the lateral or medial aspect of the nail plate into the adjacent periungual soft tissues, primarily the lateral nail fold. This mechanical impingement initiates a localized inflammatory reaction, often progressing to secondary bacterial infection, exuberant granulation tissue formation (pyogenic granuloma), and debilitating pain. The resultant pathological cascade significantly impacts patient quality of life, ambulation, and footwear tolerance, frequently necessitating medical or surgical intervention.

Epidemiologically, onychocryptosis is a highly prevalent condition globally, with reported incidence rates varying but consistently ranking it among the most common reasons for outpatient medical consultations concerning the foot. Estimates suggest that 5-10% of the general population will experience onychocryptosis during their lifetime. While it can manifest at any age, there is a pronounced bimodal distribution, with peak incidence observed in adolescents and young adults (predominantly males) and a secondary peak in the elderly. In younger cohorts, contributing factors include athletic activities leading to repetitive microtrauma, hyperhidrosis promoting skin maceration and reduced tissue resistance, and the common practice of wearing constrictive or ill-fitting footwear which applies extrinsic pressure on the nail apparatus. In the geriatric population, predisposing factors frequently include nail plate hypertrophy or dystrophy (e.g., onychomycosis, onychogryphosis), impaired manual dexterity leading to improper nail trimming, and underlying systemic comorbidities such as peripheral vascular disease, diabetes mellitus, neuropathy, and chronic edema, which compromise local tissue integrity, microcirculation, and wound healing potential. The economic burden of onychocryptosis is substantial, encompassing direct healthcare costs associated with consultations, antibiotic prescriptions, and surgical interventions, as well as indirect costs stemming from lost productivity, diminished quality of life, and potential for severe complications in vulnerable populations. Understanding its multifactorial etiology—including improper nail plate trimming (e.g., cutting too short or rounding the corners, leaving spicules), chronic external pressure from footwear, genetic predisposition to abnormal nail curvature (e.g., pincer nail, omega nail, trumpet nail), acute or repetitive microtrauma to the nail unit (e.g., stubbing injuries, tight athletic shoes), and underlying dermatological conditions (e.g., psoriasis, lichen planus affecting the nail matrix, congenital nail anomalies)—is crucial for targeted prevention and effective management strategies.

Surgical Anatomy & Biomechanics

A comprehensive understanding of the intricate anatomy and biomechanics of the human nail unit is foundational for the effective and enduring surgical management of onychocryptosis. The nail apparatus is a complex epidermal appendage, predominantly composed of the nail plate, nail matrix, nail bed, and the surrounding perionychium, each with specialized histology and function.

Key Anatomical Components:
* Nail Plate (Corpus Unguis): The visible, translucent, hard, keratinized structure (onychocytes) that serves a protective role for the distal phalanx and augments tactile sensation. It is approximately 0.3-0.6 mm thick in the hallux and grows at an average rate of 1-2 mm per month. The precise transverse curvature of the nail plate is critical; excessive transverse curvature (e.g., pincer nail deformity, where the nail edges progressively curve inward into the lateral nail folds, eventually forming a "C" or "omega" shape) significantly predisposes to onychocryptosis by increasing focal pressure on the adjacent soft tissues.
* Nail Matrix (Matrix Unguis): The germinal epithelium responsible for nail plate production. Histologically, it comprises an active germinal layer of undifferentiated epidermal cells. It extends from a few millimeters proximal to the visible proximal nail fold (underneath) distally to the lunula (the visible white crescent). The dorsal matrix contributes to the superficial nail plate, while the ventral matrix (located just distal to the lunula) contributes to the deeper layers. The integrity, complete identification, and precise ablation or excision of the offending portion of the nail matrix are the cornerstones of permanent surgical correction for recurrent onychocryptosis. Incomplete ablation leads to spicule regrowth and recurrence.
* Nail Bed (Lectulus Unguis): The sterile epidermal layer underlying the nail plate, extending from the lunula to the hyponychium. It is composed of a specialized epithelium containing longitudinal grooves and ridges that interdigitate with corresponding structures on the undersurface of the nail plate, providing adherence and facilitating distal nail growth. The nail bed contributes minimally to nail plate thickness but plays a vital role in its support and vascularization.
* Perionychium: The collective term for the specialized soft tissues surrounding the nail plate.
* Lateral Nail Folds (Sulci Unguis Laterales): The folds of skin along the lateral margins of the nail plate. These folds, comprising epidermis, dermis, and subcutaneous tissue, normally accommodate the nail plate. In onychocryptosis, the sharp edge of the nail plate aberrantly penetrates this soft tissue, inciting an inflammatory response, characterized by vasodilation, cellular infiltration, edema, and subsequent hypertrophy of the nail fold (lip of granulation tissue), which can further exacerbate the impingement and create a moist, anaerobic environment conducive to bacterial proliferation.
* Proximal Nail Fold (Eponychium): The fold of skin at the base of the nail, overlying the proximal nail matrix. The cuticle is the thin, transparent, non-living stratum corneum that extends from the proximal nail fold onto the nail plate, forming a protective seal against environmental insults and microbial invasion.
* Hyponychium: The thickened epidermal layer beneath the free distal edge of the nail plate, forming a protective barrier and preventing the entry of microorganisms beneath the nail.

Neurovascular Supply:
The vascular supply to the hallux, and specifically the nail unit, is robust and complex, originating from the digital arteries. The great toe receives its primary arterial supply from the terminal branches of the dorsalis pedis artery (via the first dorsal metatarsal artery) dorsally, and the medial and lateral plantar digital arteries (branches of the posterior tibial artery) plantarly. These vessels form extensive anastomotic networks throughout the digit, providing multiple nutrient arteries to the nail bed, matrix, and surrounding soft tissues. Meticulous hemostasis is paramount during surgical procedures to maintain a clear field and prevent hematoma formation. Venous drainage largely mirrors the arterial supply.

Sensory innervation to the hallux is primarily provided by the proper digital nerves. The medial aspect is supplied by a branch of the medial plantar nerve, and the lateral aspect by a branch of the lateral plantar nerve. The dorsal aspect typically receives innervation from branches of the deep peroneal nerve (medial dorsal cutaneous nerve) and superficial peroneal nerve (intermediate dorsal cutaneous nerve). A comprehensive digital nerve block targeting both plantar and dorsal nerve branches at the base of the toe is critical for complete intraoperative anesthesia. Prudence dictates avoidance of local anesthetic solutions containing epinephrine in digital blocks of the toes due to the theoretical risk of vasoconstriction leading to ischemia and necrosis, particularly in patients with pre-existing vascular compromise, despite ongoing debate regarding its safety in fingers. Lidocaine 1-2% without epinephrine is the widely accepted standard.

Biomechanics of Nail Growth and Impingement Pathogenesis:
Normal nail plate growth is characterized by a linear, distal progression from the matrix, maintaining its anatomical dimensions and inherent curvature within the confines of the nail folds. Onychocryptosis arises when this delicate biomechanical equilibrium is disrupted, leading to a pathological cycle:
1. Mechanical Irritation: The primary initiating event is the physical penetration of a sharp nail spicule (often resulting from improper trimming, leaving a sharp corner) or the chronic pressure from an overly curved nail plate into the lateral nail fold.
2. Inflammation and Edema: This foreign body reaction and chronic mechanical stress trigger an acute inflammatory response in the periungual tissues, manifesting as erythema, localized pain, and edema of the lateral nail fold.
3. Hypertrophic Granulation Tissue: Persistent irritation and inflammation, often compounded by secondary infection, lead to the formation of exuberant granulation tissue (pyogenic granuloma). This highly vascular tissue, characterized by neovascularization and fibroblast proliferation, protrudes over the nail plate, further encasing the offending nail edge and creating a moist, warm nidus for bacterial colonization.
4. Bacterial Superinfection: The breach in the skin barrier by the nail spicule allows opportunistic entry of common skin flora (e.g., Staphylococcus aureus , Streptococcus pyogenes , Pseudomonas aeruginosa ), leading to secondary infection, purulent discharge, cellulitis, and exacerbating the inflammatory cascade.
5. Deformity Progression: Chronic onychocryptosis can lead to permanent hypertrophy and fibrosis of the lateral nail fold, as well as nail plate dystrophy or thickening, perpetuating the cycle and making conservative management increasingly challenging.
Understanding these intricate anatomical relationships and biomechanical principles is paramount for guiding surgical decision-making, emphasizing the need to address not only the offending nail spicule but also the underlying matrix responsible for its growth and the hypertrophied soft tissues that perpetuate the condition.

Indications & Contraindications

The management algorithm for onychocryptosis progresses from conservative measures to definitive surgical intervention, with the decision point predicated on the assessment of symptom severity, chronicity, efficacy of prior treatments, and the presence of complicating factors.

Operative Indications:

• Failure of Conservative Management: Recalcitrant symptoms (intractable pain, persistent inflammation, recurrent infection, chronic drainage) despite adequate and prolonged trials (typically 4-6 weeks) of appropriate non-surgical treatments (e.g., proper nail care instruction, daily warm saline or antiseptic soaks, cotton wisps, gutter splinting, topical antibiotics for mild infection).
• Recurrent Onychocryptosis: Multiple documented episodes of the condition, particularly if previously complicated by infection or granulation tissue, indicating an inherent predisposition, an underlying anatomical abnormality, or an inadequate response to prior conservative attempts.
• Recurrent Paronychia/Cellulitis: Repeated localized soft tissue infections or episodes of cellulitis requiring systemic antibiotic therapy, highlighting the ingrown nail as a persistent nidus for bacterial entry and host immune compromise.
• Significant Pain and Functional Impairment: Debilitating, persistent pain that significantly restricts ambulation, interferes with appropriate footwear selection, limits athletic activities, or compromises performance of activities of daily living.
• Presence of Exuberant Hypertrophic Granulation Tissue: The formation of a pyogenic granuloma (exuberant granulation tissue) is a hallmark of chronic, unresolving inflammation and a physical barrier to nail growth, often preventing resolution with conservative measures alone. This tissue frequently obscures the offending nail spicule and harbors bacterial colonies.
• Chronic Drainage or Purulence: Persistent discharge from the nail fold suggestive of ongoing infection or a foreign body reaction.
• Nail Plate Deformity Predisposing to Recurrence: Intrinsic nail conditions such as severe pincer nail deformity, congenital excessively wide nail plate, pronounced transverse curvature, or significant nail dystrophy (e.g., from psoriasis, trauma) that consistently leads to impingement into the lateral nail folds.
• Diabetic Patients, Immunocompromised Patients, or Those with Peripheral Neuropathy: In these at-risk populations, even seemingly mild onychocryptosis with skin breach carries a disproportionately high risk of severe complications, including aggressive cellulitis, ulceration, osteomyelitis, and limb loss. Early and definitive surgical intervention is often preferred to mitigate these risks, sometimes even after a single episode.
• Suspected Subungual Pathology: While rare, onychocryptosis may be secondary to underlying subungual lesions such as glomus tumor, subungual exostosis, or malignant melanoma, which necessitate excisional biopsy or definitive surgical removal.

Contraindications for Operative Management:

• Absolute Contraindications:
  • Acute, Uncontrolled, Spreading Cellulitis or Osteomyelitis: While localized infection (paronychia) is often an indication for simultaneous surgical drainage and definitive matricectomy, diffuse, spreading cellulitis of the digit or suspected osteomyelitis requires a preliminary course of systemic antibiotic therapy and resolution of the acute infection prior to elective surgical intervention. Performing definitive matricectomy in this setting risks disseminating the infection.
  • Severe Peripheral Arterial Disease (PAD): Critical limb ischemia is an absolute contraindication for elective foot surgery due to the profoundly elevated risk of non-healing wounds, infection, and potential digit loss. Comprehensive vascular assessment (e.g., Ankle-Brachial Index (ABI), Toe-Brachial Index (TBI), transcutaneous oximetry) demonstrating compromised perfusion is mandatory.
  • Uncontrolled Coagulopathy: Patients with severe bleeding diatheses (e.g., hemophilia, severe von Willebrand disease) or those on high-dose anticoagulant medications that cannot be safely interrupted pose an unacceptable hemorrhagic risk.
  • Known Allergy to Local Anesthetics: Requires careful consideration of alternative anesthetic techniques or agents; however, local anesthetic is nearly universal for these procedures.
• Relative Contraindications:
  • Mild Symptoms/First Episode: In the absence of infection, significant pain, or granulation tissue, an initial trial of rigorous conservative management is often warranted.
  • Pregnancy: Elective surgical procedures are generally deferred until the postpartum period unless symptoms are severe and unresponsive to conservative measures.
  • Uncontrolled Systemic Diseases: While diabetes is an indication for aggressive management, poorly controlled diabetes (e.g., persistently elevated HbA1c) or other systemic conditions that significantly impair wound healing (e.g., severe malnutrition, active autoimmune vasculitis) should ideally be optimized prior to elective surgery to mitigate post-operative complication risks.
  • Active Fungal Infection (Onychomycosis): While not an absolute contraindication to partial nail avulsion, the efficacy of chemical matricectomy may be reduced, and the risk of post-operative infection increased, if severe onychomycosis is not concomitantly addressed with antifungal therapy.

Operative vs. Non-Operative Indications

Pre-Operative Planning & Patient Positioning

Meticulous pre-operative planning is indispensable for optimizing surgical outcomes, minimizing complications, and ensuring patient safety in onychocryptosis management. This includes comprehensive patient evaluation, thorough informed consent, appropriate anesthetic selection, and stringent sterile field preparation.

1. Patient Evaluation and History:

• Detailed History: Elicit the exact chronicity of symptoms, number of previous episodes, prior treatments (conservative and surgical, detailing type and outcome) and their efficacy. Quantify associated pain level using a standardized scale (e.g., VAS) and document functional limitations (e.g., specific footwear intolerance, restrictions on athletic activities or daily living). Inquire about the presence and character of drainage (serous, purulent, sanguineous) and any history of recurrent infection, including organisms if cultured and antibiotic courses. Critically assess current nail care practices, footwear choices, and occupational/recreational exposures.
• Medical Comorbidities: Systematically review the patient's past medical history. Specifically ascertain history of diabetes mellitus (including duration, control with recent HbA1c levels, and presence of micro/macrovascular complications), peripheral vascular disease (documenting claudication, rest pain, prior revascularization procedures, or known arterial insufficiency), peripheral neuropathy, immunosuppression (e.g., HIV, corticosteroid use, chemotherapy), autoimmune disorders (e.g., rheumatoid arthritis, lupus), and bleeding diatheses (e.g., hemophilia, liver disease, family history). Document all current medications, paying particular attention to anticoagulants (warfarin, DOACs), antiplatelet agents (aspirin, clopidogrel), and immunosuppressants, and plan for their safe management perioperatively.
• Allergies: Document all known allergies comprehensively, especially to local anesthetics, antibiotics, antiseptic solutions (e.g., iodine, chlorhexidine), and latex.

2. Physical Examination:

• General Assessment: Beyond the local pathology, assess the patient's overall health status and identify any systemic signs of infection (e.g., fever, lymphadenopathy) or vascular compromise.
• Foot and Toe Examination:
  • Inspection: A meticulous visual examination is paramount. Accurately identify the specific offending nail edge (lateral, medial, or both, and which toe(s)). Characterize the extent of nail plate penetration into the nail fold, presence and size of hypertrophic granulation tissue, degree of erythema, localized edema, signs of purulent drainage, or spreading cellulitis (distinguish local inflammation from diffuse infection). Assess overall nail plate morphology (e.g., pincer nail deformity, congenital nail plate widening, onychomycosis, onychogryphosis, dystrophy, subungual hyperkeratosis). Examine for interdigital maceration or other concomitant foot pathologies.
  • Palpation: Gently palpate the periungual tissues to assess tenderness, warmth, firmness, and fluctuance (suggesting abscess formation).
  • Vascular Assessment: Crucial for all foot procedures, particularly in at-risk patients. Palpate pedal pulses (dorsalis pedis, posterior tibial). In diabetic, elderly, or symptomatic patients, formal vascular assessment is mandatory: handheld Doppler ultrasound for arterial signals, Ankle-Brachial Index (ABI), or Toe-Brachial Index (TBI). A TBI < 0.6 or absolute toe pressure < 30 mmHg signifies significant PAD and may contraindicate elective surgery.
  • Neurological Assessment: Assess protective sensation using monofilament testing (e.g., 10g Semmes-Weinstein) or vibratory sensation, especially in diabetic or neuropathic patients, to gauge their risk for post-operative complications related to unrecognized trauma or impaired wound healing, and their ability to comply with specific wound care instructions.
• Imaging:
  • Plain Radiographs: Typically not indicated for routine, uncomplicated onychocryptosis. However, AP, lateral, and oblique views of the affected distal phalanx are mandatory if osteomyelitis of the distal phalanx is suspected (e.g., persistent deep infection unresponsive to antibiotics, chronic ulceration, extensive purulence reaching bone), or if an underlying bony pathology such as a subungual exostosis or osteochondroma is considered in the differential diagnosis.
  • MRI: May be considered for definitive diagnosis of osteomyelitis if plain radiographs are equivocal, or for detailed evaluation of soft tissue tumors.
• Laboratory Investigations: Not routinely required. If acute infection is present or systemic comorbidities (e.g., uncontrolled diabetes) exist, consider CBC with differential, inflammatory markers (ESR, CRP), and blood glucose/HbA1c. Swab culture of purulent discharge is indicated if infection is chronic, recurrent, or unresponsive to empiric antibiotics, to guide targeted therapy.

3. Informed Consent:

A comprehensive, detailed discussion with the patient is paramount. This includes explaining the diagnosis, the natural history of onychocryptosis, and a thorough review of all available treatment options—both conservative and surgical. For surgical intervention, clearly articulate the specific procedure planned (e.g., partial nail avulsion with phenol matricectomy), its expected outcomes (e.g., high success rate for recurrence prevention), its permanent nature, and potential complications. Complications to specifically discuss include: post-operative pain, infection, recurrence (emphasize that no procedure has 100% success), nail deformity (e.g., narrowing, discoloration, spike formation), prolonged drainage, allergic reactions, hypertrophic scarring, anesthetic risks, and rarely, osteomyelitis or nerve injury. Detail the anticipated post-operative care regimen and the estimated recovery timeline. Ensure the patient fully comprehends the information and has ample opportunity to ask questions before signing the consent form.

4. Anesthetic Considerations:

• Local Anesthesia: The preferred method for onychocryptosis surgery is a meticulous digital nerve block.
  • Technique: Typically a ring block involving four injections at the base of the toe: two dorsal injections (medial and lateral) and two plantar injections (medial and lateral), targeting the proper digital nerves. The needle should be advanced slowly, aspirating prior to injection to avoid intravascular administration.
  • Agent: 1-2% Lidocaine without epinephrine is the gold standard for rapid onset anesthesia. Bupivacaine (0.25-0.5%) can be added or used alone for prolonged post-operative analgesia (onset time is slower). The use of epinephrine-containing solutions is generally contraindicated in digital blocks of the toes due to the theoretical, albeit rare, risk of vasoconstriction leading to ischemia and necrosis, especially in patients with compromised digital circulation.
  • Volume: Inject slowly, typically 2-3 mL per injection site, ensuring proper nerve blockade without excessive tissue distension which can compromise local blood flow. Allow sufficient time (5-10 minutes) for the block to take full effect before commencing surgery.
• Systemic Sedation: Rarely required for this procedure, but may be considered for extremely anxious patients, typically in an operating room setting with appropriate monitoring.

5. Tourniquet Use:

• A digital tourniquet is essential for creating a bloodless field, which significantly enhances visualization and precision during matricectomy, particularly for chemical ablation where residual blood inactivates the phenol.
• Options: Common methods include a Penrose drain secured with a hemostat, a commercial finger/toe tourniquet (e.g., D-ring tourniquet), or a rolled gauze secured with surgical tape. A blood pressure cuff inflated on the ankle can also serve as a tourniquet for the entire foot.
• Monitoring: Tourniquet time must be meticulously monitored and kept to a minimum (typically <15-20 minutes for a toe) to prevent ischemic damage. Release and reperfuse if the procedure extends beyond this timeframe.

6. Patient Positioning & Surgical Prep:

• Positioning: The patient is positioned supine on the operating table. The affected foot is positioned comfortably on a sterile footrest, pillow, or towel roll to ensure optimal surgical access and ergonomics for the surgeon.
• Sterile Preparation: The entire foot, extending proximally above the ankle, is prepped using an appropriate antiseptic solution (e.g., povidone-iodine solution or chlorhexidine gluconate solution). Ensure thorough scrubbing and allow appropriate drying time according to product instructions.
• Draping: Sterile drapes are applied to create a wide, sterile operative field, exposing only the affected toe. Adhesive fenestrated drapes may be used to secure the field and prevent contamination.
• Instrumentation: Ensure all necessary instruments are readily available and sterile: local anesthetic, appropriate syringes and needles, digital tourniquet, straight hemostats, curved hemostats, nail splitter, English anvil, small iris scissors, scalpel (No. 15 blade for sharp dissection, No. 10 for larger incisions if applicable), fine curette (for granulation tissue), phenol solution (88% or 90% aqueous), multiple small cotton-tipped applicators, 70% isopropyl alcohol for neutralization, sterile saline irrigation, non-adherent dressing material (e.g., Xeroform, petrolatum gauze), sterile gauze rolls, and adhesive tape. For surgical matricectomy, additionally require fine tissue forceps (e.g., Adson with teeth), needle holders, and appropriate absorbable sutures (e.g., 4-0 or 5-0 chromic gut, Monocryl).

Detailed Surgical Approach / Technique

The definitive surgical management of onychocryptosis aims to permanently narrow the nail plate by ablating or excising the offending portion of the nail matrix, often concurrently with partial nail avulsion and resection of hypertrophic soft tissue. The choice of technique is guided by the surgeon's expertise, the chronicity and severity of the condition, and the presence or absence of significant infection or nail deformity. The most commonly performed and highly effective permanent procedure is partial nail avulsion with chemical matricectomy (phenolization). Surgical matricectomy techniques (e.g., Winograd, Zadek) offer viable alternatives, particularly in specific clinical scenarios.

1. Partial Nail Avulsion with Chemical Matricectomy (Phenolization):

This widely adopted technique is considered a highly effective, minimally invasive procedure for permanent treatment of recurrent or severe onychocryptosis.

Step-by-Step Dissection:

1. Anesthesia and Tourniquet Application:

   • Perform a meticulous digital nerve block (e.g., ring block with 1-2% Lidocaine without epinephrine), ensuring complete anesthesia of the affected digit. Allow 5-10 minutes for full effect.
   • Apply a sterile digital tourniquet at the base of the toe. This is a critical step to achieve an exsanguinated, bloodless surgical field, which is paramount for clear visualization and to prevent dilution or inactivation of the chemical agent by blood.

2. Sterile Preparation of the Operative Field:

   • Confirm sterile prep and drape of the foot, isolating the affected toe.
   • Precisely identify the offending lateral nail edge (or medial, if bilateral pathology).

3. Partial Nail Avulsion:

   • Using a sterile nail splitter (e.g., Miller, Sklar) or fine, straight iris scissors, carefully introduce the instrument beneath the offending lateral nail plate. Advance the instrument proximally, ensuring it remains parallel to the lateral nail fold, extending fully to the nail matrix beneath the proximal nail fold. The incision in the nail plate should be made longitudinally, approximately 2-4 mm medial to the actual nail plate edge, to ensure adequate resection without compromising the stability of the remaining nail.
   • Once the nail spicule is completely separated from the nail bed and matrix, grasp the freed nail fragment (spicule) firmly with an English anvil or a straight hemostat. Gently but decisively avulse the nail spicule proximally with a slight rotatory motion, ensuring complete removal of the fragment from its attachment to the matrix without tearing the adjacent intact nail plate or causing undue trauma to the nail bed. Confirm no residual spicules remain embedded in the nail fold.
   • Thoroughly inspect the nail bed and matrix where the nail fragment was removed. Identify and carefully curette or sharply excise any hypertrophic granulation tissue that may be present within the lateral nail gutter. This step provides better access to the germinal matrix and reduces post-operative inflammatory bulk.

4. Chemical Matricectomy (Phenolization):

   • Crucial Drying: This is the most critical step for successful phenolization. Completely dry the lateral nail gutter, exposed matrix, and nail bed using multiple small, tightly wrapped sterile cotton swabs. Any residual blood, purulence, or serous exudate will significantly dilute and inactivate the phenol solution, leading to treatment failure and recurrence. A dry field is paramount.
   • Phenol Application:
     • Dip a small, tightly wrapped cotton-tipped applicator (e.g., Q-tip with excess cotton removed or a specialized phenol applicator) into 88% or 90% aqueous phenol solution. Remove any excess solution by dabbing the applicator on a sterile gauze pad.
     • Carefully insert the phenol-soaked applicator deeply and precisely into the lateral nail gutter, ensuring direct and continuous contact with the exposed germinal matrix in the area where the nail spicule was removed. Apply moderate, firm pressure for 60 seconds.
     • Perform a total of 3-4 sequential applications of phenol , each lasting 60 seconds, using a fresh, phenol-soaked applicator for each application. This multi-application protocol ensures adequate chemical ablation (denaturation of proteins and cellular destruction) of the matrix cells responsible for producing the ingrown nail segment, thereby achieving permanent cessation of growth in that specific area.
   • Neutralization/Rinsing: After the final phenol application, thoroughly irrigate the nail gutter and surrounding tissues with liberal amounts of 70% isopropyl alcohol for 30-60 seconds. This step serves to neutralize any residual active phenol and flush away necrotic tissue debris. Some surgeons prefer continuous saline irrigation; however, alcohol is more effective at neutralization.
   • Final Inspection: Carefully inspect the treated area to ensure no phenol has spread to unaffected skin, which could cause a chemical burn.

5. Tourniquet Release and Hemostasis:

   • Gently release the digital tourniquet. Expect some serosanguinous oozing from the treated nail gutter, which is normal and indicates reperfusion.
   • Achieve meticulous hemostasis with gentle, sustained pressure using sterile gauze. Silver nitrate sticks can be sparingly used for pinpoint bleeding points, but usually are not necessary after adequate phenolization which also has some cauterizing effect.

6. Dressing Application:

   • Apply a non-adherent dressing (e.g., Xeroform, bacitracin ointment on Telfa, petrolatum-impregnated gauze) directly into the nail gutter and over the treated area. This prevents adhesion of the outer dressing and facilitates drainage.
   • Cover with sterile gauze rolls and secure with a light compressive bandage (e.g., Kling or Coban wrap). Avoid excessive compression, which can compromise digital circulation, particularly in at-risk patients. The dressing should protect the wound and absorb drainage without being occlusive.

2. Surgical Matricectomy (e.g., Winograd, Zadek Procedures):

These techniques involve surgical excision of the lateral nail matrix, offering an alternative to chemical ablation, particularly in cases of very wide nail plates, significant hypertrophy of the nail folds, previous phenol failure, or when phenolization is contraindicated (e.g., severe peripheral neuropathy where phenol burn risk is high).

A. Winograd Procedure (Partial Lateral Matrix Excision):
This technique involves the excision of a wedge of soft tissue and the underlying lateral nail matrix, typically preserving the nail plate.

1. Anesthesia and Tourniquet: As described above.
2. Partial Nail Avulsion: Avulse the offending lateral nail spicule as described in step 3 of phenolization.
3. Incisions: Two elliptical, convergent incisions are made on the lateral nail fold, extending proximally into the proximal nail fold (over the matrix) and distally along the nail plate margin. The incisions encompass the hypertrophied soft tissue and extend deep to the periosteum of the distal phalanx. The width of the excised wedge should correspond to the width of the avulsed nail segment.
4. Wedge Excision: The elliptical wedge of skin, subcutaneous tissue, nail bed, and the underlying lateral 2-4 mm of the germinal nail matrix is excised en bloc. Care is taken to identify and completely remove the matrix down to the periosteum of the distal phalanx, without violating the bone unless a subungual exostosis is concurrently removed.
5. Hemostasis: Achieve meticulous hemostasis using electrocautery (bipolar preferred for toes) or fine ligatures.
6. Closure: The skin edges of the nail fold are approximated with fine absorbable sutures (e.g., 4-0 or 5-0 chromic gut, Monocryl, or PDS) in an interrupted fashion. The aim is to re-approximate the nail fold to the remaining nail plate, narrowing the nail sulcus.
7. Dressing: As described above.

B. Zadek Procedure (Total Proximal Matrix Excision):
This procedure involves the complete excision of the entire proximal nail fold and underlying matrix, leading to complete and permanent nail plate ablation. It is generally reserved for severe, diffuse nail dystrophies (e.g., onychogryphosis) or recurrent onychocryptosis involving the entire nail plate where complete removal is desired, or in cases of intractable chronic paronychia. It results in an absent nail plate.

1. Anesthesia and Tourniquet: As described above.
2. Incision: A transverse elliptical or "W"-shaped incision is made at the base of the proximal nail fold. The distal limb of the incision is typically at the level of the lunula, and the proximal limb extends slightly proximal to the nail matrix.
3. Flap Elevation and Nail Avulsion: The entire nail plate is typically totally avulsed. The proximal nail fold is sharply dissected and elevated as a flap, carefully exposing the entire germinal matrix underneath.
4. Matrix Excision: The entire germinal matrix is meticulously dissected and excised from the underlying periosteum of the distal phalanx using a scalpel. All remnants must be identified and removed to prevent regrowth of nail spicules or an entire deformed nail plate. The nail bed is often included in the excision.
5. Closure: The proximal nail fold flap is then re-draped and secured to the nail bed or underlying fibrous tissue with sutures to create a smooth, nail-less digit.
6. Dressing: As described above.

Internervous Planes, Reduction, and Fixation:

For onychocryptosis surgery, the terms "internervous planes," "reduction," and "fixation" are not applicable in their traditional orthopedic context of skeletal surgery.
* Internervous Planes: While a thorough understanding of digital nerve anatomy is crucial for effective nerve blocks, surgical dissection in onychocryptosis typically remains superficial to major neurovascular bundles, focusing on the epidermal and dermal layers of the nail unit. Dissection is primarily within soft tissue planes to identify and ablate/excise the nail matrix. The primary objective is to separate the nail plate from the nail bed, and the matrix from the periosteum.
* Reduction: There is no "reduction" of a fracture or dislocation in onychocryptosis surgery. Metaphorically, "reduction" could refer to the permanent reduction of the nail plate width or the lateral nail fold hypertrophy.
* Fixation: No bony or joint structures are primarily involved or require fixation. The goal is permanent destruction or removal of the offending matrix cells, which is achieved through chemical or surgical ablation, not physical fixation.

Complications & Management

While generally safe and effective, surgical procedures for onychocryptosis, like all interventions, carry potential risks. Academic orthopedic surgeons must be adept at identifying and managing these complications to ensure optimal patient outcomes.

Common Complications, Incidence, and Salvage Strategies:

| Complication | Approximate Incidence (Varies by technique) | Management / Salvage Strategies |

| | |
| Duration of Current Symptoms | Persistent over weeks to months, often worsening despite previous interventions. | Less than 4-6 weeks, mild progression. |
| Previous Surgical Interventions | History of previous simple nail avulsion or incomplete matricectomy with recurrence. | No prior surgical intervention for onychocryptosis. |
| Nail Fold Condition | Significant hypertrophy of the lateral nail fold, chronic inflammation, or cellulitis. | Mild inflammation, no significant hypertrophy or acute cellulitis. |

Pre-Operative Planning & Patient Positioning

Meticulous pre-operative planning is indispensable for optimizing surgical outcomes and minimizing complications in onychocryptosis management. This involves a comprehensive patient evaluation, thorough informed consent, appropriate anesthetic selection, and stringent sterile field preparation.

1. Patient Evaluation and History:

• Detailed History: Elicit the exact chronicity of symptoms, number of previous episodes, prior treatments (conservative and surgical, detailing type and outcome) and their efficacy. Quantify associated pain level using a standardized scale (e.g., Visual Analog Scale, VAS) and document functional limitations (e.g., specific footwear intolerance, restrictions on athletic activities, occupational impact, or limitations in activities of daily living). Inquire about the presence and character of drainage (serous, purulent, sanguineous) and any history of recurrent infection, including organisms if cultured and antibiotic courses. Critically assess current nail care practices (trimming technique, frequency), footwear choices (fit, material, toe box), and occupational/recreational exposures that may contribute to the condition.
• Medical Comorbidities: Systematically review the patient's past medical history. Specifically ascertain history of diabetes mellitus (including duration, control with recent HbA1c levels, and presence of micro/macrovascular complications such as retinopathy, nephropathy, or peripheral neuropathy), peripheral vascular disease (documenting claudication, rest pain, prior revascularization procedures, or known arterial insufficiency), peripheral neuropathy, immunosuppression (e.g., HIV, organ transplant, chronic corticosteroid use, chemotherapy), autoimmune disorders (e.g., rheumatoid arthritis, lupus), and bleeding diatheses (e.g., hemophilia, severe von Willebrand disease, liver disease, family history of bleeding). Document all current medications, paying particular attention to anticoagulants (warfarin, direct oral anticoagulants), antiplatelet agents (aspirin, clopidogrel), and immunosuppressants, and formulate a perioperative management plan for these agents in consultation with prescribing physicians.
• Allergies: Document all known allergies comprehensively, especially to local anesthetics, antibiotics, antiseptic solutions (e.g., povidone-iodine, chlorhexidine), and latex.

2. Physical Examination:

• General Assessment: Beyond the local pathology, assess the patient's overall health status and identify any systemic signs of infection (e.g., fever, regional lymphadenopathy) or overt vascular compromise.
• Foot and Toe Examination:
  • Inspection: A meticulous visual examination is paramount. Accurately identify the specific offending nail edge (lateral, medial, or both, and which specific toe(s) are involved). Characterize the extent of nail plate penetration into the nail fold, presence and size of hypertrophic granulation tissue, degree of erythema, localized edema, signs of purulent drainage, or spreading cellulitis (it is crucial to distinguish localized paronychia from diffuse, ascending cellulitis). Assess overall nail plate morphology (e.g., pincer nail deformity, congenital nail plate widening, onychomycosis, onychogryphosis, dystrophy, subungual hyperkeratosis). Examine for interdigital maceration, dermatophytosis, or other concomitant foot pathologies.
  • Palpation: Gently palpate the periungual tissues to assess tenderness, warmth, firmness, and fluctuance (suggesting abscess formation necessitating drainage).
  • Vascular Assessment: Crucial for all foot procedures, especially in at-risk patients (diabetics, elderly, smokers, or those with known vascular history). Palpate pedal pulses (dorsalis pedis, posterior tibial). In patients with risk factors or diminished pulses, formal vascular assessment is mandatory: handheld Doppler ultrasound for arterial signals, Ankle-Brachial Index (ABI), or Toe-Brachial Index (TBI). A TBI < 0.6 or absolute toe pressure < 30 mmHg signifies significant PAD and may contraindicate elective surgery due to impaired healing potential.
  • Neurological Assessment: Assess protective sensation using monofilament testing (e.g., 10g Semmes-Weinstein) or vibratory sensation, particularly in diabetic or neuropathic patients, to gauge their risk for post-operative complications related to unrecognized trauma or impaired wound healing, and their ability to comply with specific wound care instructions.
• Imaging:
  • Plain Radiographs: Typically not indicated for routine, uncomplicated onychocryptosis. However, AP, lateral, and oblique views of the affected distal phalanx are mandatory if osteomyelitis of the distal phalanx is suspected (e.g., persistent deep infection unresponsive to antibiotics, chronic ulceration, extensive purulence reaching bone, or exposed bone), or if an underlying bony pathology such as a subungual exostosis or osteochondroma is considered in the differential diagnosis.
  • MRI: May be considered for definitive diagnosis of osteomyelitis if plain radiographs are equivocal or show subtle changes, or for detailed evaluation of soft tissue tumors.
• Laboratory Investigations: Not routinely required for uncomplicated cases. If acute infection is present or systemic comorbidities (e.g., uncontrolled diabetes) exist, consider complete blood count with differential, inflammatory markers (erythrocyte sedimentation rate, C-reactive protein), and blood glucose/HbA1c. Swab culture of purulent discharge is indicated if infection is chronic, recurrent, or unresponsive to empiric antibiotics, to guide targeted antimicrobial therapy.

3. Informed Consent:

A comprehensive, detailed discussion with the patient is paramount. This includes explaining the diagnosis, the natural history of onychocryptosis, and a thorough review of all available treatment options—both conservative and surgical, outlining their respective success rates, risks, and benefits. For surgical intervention, clearly articulate the specific procedure planned (e.g., partial nail avulsion with chemical matricectomy (phenolization), or partial surgical matricectomy), its expected outcomes (e.g., high success rate for recurrence prevention, but not 100%), its permanent nature (for matricectomy), and potential complications. Complications to specifically discuss include: post-operative pain, infection, recurrence (emphasize that no procedure has 100% success and identify factors increasing risk), nail deformity (e.g., narrowing of the nail plate, discoloration, formation of a "spicule" or residual nail fragment, dystrophy), prolonged drainage, hypertrophic scarring, neurovascular injury, and anesthetic risks. Detail the anticipated post-operative care regimen, expected wound healing trajectory, and the estimated recovery timeline for return to normal activities and footwear. Ensure the patient fully comprehends the information, including the permanence of matricectomy, and has ample opportunity to ask questions before providing informed consent.

4. Anesthetic Considerations:

• Local Anesthesia: The preferred and most common method for onychocryptosis surgery is a meticulously performed digital nerve block.
  • Technique: Typically a ring block involving four injections at the base of the toe: two dorsal injections (medial and lateral) and two plantar injections (medial and lateral), targeting the proper digital nerves. The needle should be advanced slowly, aspirating prior to each injection to avoid inadvertent intravascular administration. The block should be administered slowly, minimizing discomfort.
  • Agent: 1-2% Lidocaine without epinephrine is the gold standard for rapid onset anesthesia (onset typically within 5-10 minutes). Bupivacaine (0.25-0.5%) can be added or used alone for prolonged post-operative analgesia (onset time is slower, 10-20 minutes). The use of epinephrine-containing local anesthetic solutions is generally contraindicated in digital blocks of the toes due to the theoretical, albeit rare, risk of vasoconstriction leading to ischemia and necrosis, especially in patients with pre-existing compromised digital circulation (e.g., diabetics, smokers, PAD). Current evidence supports safety in fingers, but for toes, prudence dictates avoidance.
  • Volume: Inject slowly, typically 2-3 mL per injection site, ensuring proper nerve blockade without excessive tissue distension which can compromise local blood flow. Allow sufficient time (5-10 minutes) for the block to take full effect before commencing surgical manipulation. Confirm adequate anesthesia by assessing sensation prior to incision.
• Systemic Sedation: Rarely required for this procedure, which is typically performed under local anesthesia alone in an outpatient setting. However, it may be considered for extremely anxious or uncooperative patients, ideally in an operating room setting with appropriate monitoring (pulse oximetry, cardiac monitoring, blood pressure).

5. Tourniquet Use:

• A digital tourniquet is essential for creating a bloodless surgical field. This significantly enhances visualization, precision, and safety during matricectomy, particularly for chemical ablation where residual blood or exudate will inactivate the phenol solution.
• Options: Common methods include a sterile Penrose drain secured with a hemostat, a commercial finger/toe tourniquet (e.g., D-ring tourniquet), or a rolled gauze secured with surgical tape. For more extensive procedures, a pneumatic blood pressure cuff inflated on the ankle can serve as a tourniquet for the entire foot.
• Monitoring: Tourniquet time must be meticulously monitored and kept to a minimum (typically <15-20 minutes for a toe) to prevent ischemic damage. If the procedure extends beyond this timeframe, the tourniquet should be temporarily deflated to allow reperfusion before re-inflation, if clinically safe and necessary.

6. Patient Positioning & Surgical Prep:

• Positioning: The patient is positioned supine on the operating table. The affected foot is positioned comfortably on a sterile footrest, pillow, or towel roll to ensure optimal surgical access, ergonomics for the surgeon, and patient comfort.
• Sterile Preparation: The entire foot, extending proximally above the ankle, is meticulously prepped using an appropriate antiseptic solution (e.g., povidone-iodine solution or chlorhexidine gluconate solution). Ensure thorough scrubbing and allow appropriate drying time according to product instructions to maximize efficacy.
• Draping: Sterile drapes are applied to create a wide, sterile operative field, meticulously isolating the affected toe. Adhesive fenestrated drapes may be used to secure the field and prevent inadvertent contamination from surrounding skin.
• Instrumentation: Ensure all necessary instruments are readily available and sterile: local anesthetic, appropriate syringes and needles, digital tourniquet, straight hemostats, curved hemostats, nail splitter, English anvil, small iris scissors, scalpel (No. 15 blade for fine dissection, No. 10 for larger incisions if applicable), fine curette (for granulation tissue), phenol solution (88% or 90% aqueous), multiple small, tightly wrapped cotton-tipped applicators (e.g., "Q-tips"), 70% isopropyl alcohol for neutralization, sterile saline irrigation, non-adherent dressing material (e.g., Xeroform, petrolatum-impregnated gauze), sterile gauze rolls, and adhesive tape. For surgical matricectomy, additionally require fine tissue forceps (e.g., Adson with teeth), fine needle holders, and appropriate absorbable sutures (e.g., 4-0 or 5-0 chromic gut, Monocryl).

Detailed Surgical Approach / Technique

The definitive surgical management of onychocryptosis primarily aims to permanently narrow the nail plate by ablating or excising the offending portion of the nail matrix, often concurrently with partial nail avulsion and resection of hypertrophic soft tissue. The selection of technique is guided by the surgeon's expertise, the chronicity and severity of the condition, presence or absence of significant infection, and the underlying nail deformity. The most commonly performed and highly effective permanent procedure is partial nail avulsion with chemical matricectomy (phenolization). Surgical matricectomy techniques (e.g., Winograd, Zadek) offer viable alternatives, particularly in specific clinical scenarios or when chemical ablation is contraindicated or has failed.

1. Partial Nail Avulsion with Chemical Matricectomy (Phenolization):

This widely adopted technique is considered the gold standard for recurrent or severe onychocryptosis, demonstrating high success rates and relatively low invasiveness.

Step-by-Step Dissection:

1. Anesthesia and Tourniquet Application:

   • Perform a meticulous digital nerve block (e.g., ring block with 1-2% Lidocaine without epinephrine), ensuring complete anesthesia of the affected digit. Allow a minimum of 5-10 minutes for the block to achieve full efficacy.
   • Apply a sterile digital tourniquet at the base of the toe. This is a critical step to achieve an exsanguinated, bloodless surgical field, which is paramount for clear visualization of the matrix and to prevent dilution or inactivation of the chemical agent by blood or tissue fluids.

2. Sterile Preparation of the Operative Field:

   • Confirm sterile prep and drape of the foot, ensuring only the affected toe is exposed within the sterile field.
   • Precisely identify and confirm the offending lateral nail edge (or medial, if bilateral pathology, or if performing bilateral procedures).

3. Partial Nail Avulsion:

   • Using a sterile nail splitter (e.g., Miller, Sklar) or fine, straight iris scissors, carefully introduce the instrument beneath the offending lateral nail plate. The instrument should be advanced proximally, ensuring it remains parallel to the lateral nail fold, extending fully to the nail matrix beneath the proximal nail fold. The longitudinal incision in the nail plate should be made approximately 2-4 mm medial to the actual nail plate edge, parallel to the nail fold, to ensure adequate resection of the offending segment without compromising the structural integrity or stability of the remaining nail plate.
   • Once the nail spicule is completely separated from the nail bed and matrix, grasp the freed nail fragment (spicule) firmly with an English anvil or a straight hemostat. Gently but decisively avulse the nail spicule proximally with a slight rotatory motion, ensuring complete removal of the fragment from its attachment to the matrix without tearing the adjacent intact nail plate or causing undue trauma to the nail bed. Thoroughly inspect the nail gutter to confirm no residual spicules remain embedded in the nail fold, as these can be a source of recurrence.
   • If present, sharply excise or meticulously curette any hypertrophic granulation tissue that may be present within the lateral nail gutter using a No. 15 scalpel blade or a fine curette. This step improves direct access to the germinal matrix, removes chronically inflamed tissue, and reduces post-operative bulk and drainage.

4. Chemical Matricectomy (Phenolization):

   • Crucial Drying: This is the single most critical step for successful phenolization. Completely dry the lateral nail gutter, the exposed nail matrix (the pale, glistening tissue at the base of the avulsed nail segment), and the nail bed using multiple small, tightly wrapped sterile cotton swabs. Any residual blood, purulence, or serous exudate will significantly dilute and inactivate the phenol solution, leading to treatment failure and recurrence. A completely dry, exsanguinated field is paramount for effective chemical ablation.
   • Phenol Application:
     • Dip a small, tightly wrapped cotton-tipped applicator (e.g., a standard Q-tip with excess cotton removed or a specialized phenol applicator) into 88% or 90% aqueous phenol solution. Remove any excess solution by dabbing the applicator gently on a sterile gauze pad to prevent unintended tissue damage.
     • Carefully insert the phenol-soaked applicator deeply and precisely into the lateral nail gutter, ensuring direct and continuous contact with the exposed germinal matrix in the area where the nail spicule was removed. Apply moderate, firm pressure for 60 seconds.
     • Perform a total of 3-4 sequential applications of phenol , each lasting 60 seconds, using a fresh, phenol-soaked applicator for each application. This multi-application protocol ensures adequate chemical ablation (denaturation of cellular proteins and irreversible cellular destruction) of the matrix cells responsible for producing the ingrown nail segment, thereby achieving permanent cessation of growth in that specific area. The cumulative contact time and concentration are critical factors for efficacy.
   • Neutralization/Rinsing: After the final phenol application, thoroughly irrigate the nail gutter and surrounding tissues with liberal amounts of 70% isopropyl alcohol for 30-60 seconds. This step serves to neutralize any residual active phenol and to flush away necrotic tissue debris. Some surgeons prefer continuous saline irrigation; however, alcohol is chemically more effective at neutralizing phenol.
   • Final Inspection: Carefully inspect the treated area to ensure no phenol has inadvertently spread to unaffected skin, which could cause a chemical burn and potential scar.

5. Tourniquet Release and Hemostasis:

   • Gently release the digital tourniquet. Expect some serosanguinous oozing from the treated nail gutter, which is a normal response to reperfusion and tissue necrosis.
   • Achieve meticulous hemostasis with gentle, sustained pressure using sterile gauze. Silver nitrate sticks can be sparingly used for pinpoint bleeding points, but usually are not necessary after adequate phenolization, which itself exerts a mild cauterizing effect.

6. Dressing Application:

   • Apply a non-adherent dressing (e.g., Xeroform, bacitracin ointment on Telfa, petrolatum-impregnated gauze) directly into the nail gutter and over the treated area. This prevents adhesion of the outer dressing, promotes a moist wound healing environment, and facilitates drainage.
   • Cover with sterile gauze rolls and secure with a light compressive bandage (e.g., Kling or Coban wrap). Avoid excessive compression, which can compromise digital circulation, particularly in at-risk patients (e.g., diabetics, those with PAD). The dressing should protect the wound, absorb drainage, and maintain a clean environment without being overly occlusive.

2. Surgical Matricectomy (e.g., Winograd, Zadek Procedures):

These techniques involve surgical excision of the lateral nail matrix, offering an alternative to chemical ablation. They are particularly useful in cases of very wide nail plates, significant hypertrophy of the nail folds that require tissue reduction, previous phenol failure, or when phenolization is contraindicated (e.g., severe peripheral neuropathy where phenol burn risk is high, or allergy).

A. Winograd Procedure (Partial Lateral Matrix Excision):
This technique involves the excision of a precise wedge of soft tissue and the underlying lateral nail matrix, typically preserving the majority of the nail plate.

1. Anesthesia and Tourniquet: As described in step 1 of phenolization.
2. Partial Nail Avulsion: Avulse the offending lateral nail spicule as described in step 3 of phenolization. This exposes the underlying nail bed and matrix.
3. Incisions: Using a No. 15 scalpel blade, make two elliptical, convergent incisions on the lateral nail fold. The proximal incision extends slightly into the proximal nail fold (over the matrix), and the distal incision parallels the nail plate margin. The incisions should be deep, encompassing the hypertrophied soft tissue and extending down to the periosteum of the distal phalanx. The width of the excised wedge should precisely correspond to the width of the avulsed nail segment (typically 2-4 mm).
4. Wedge Excision: The elliptical wedge of skin, subcutaneous tissue, nail bed, and the underlying lateral 2-4 mm of the germinal nail matrix is carefully dissected and excised en bloc. Care is taken to identify and completely remove the matrix down to the periosteum of the distal phalanx, avoiding violation of the bone unless a subungual exostosis is concurrently removed. Confirm complete matrix removal to prevent recurrence.
5. Hemostasis: Achieve meticulous hemostasis using electrocautery (bipolar cautery is preferred for precise coagulation in toes) or fine ligatures.
6. Closure: The skin edges of the nail fold are approximated with fine absorbable sutures (e.g., 4-0 or 5-0 chromic gut, Monocryl, or PDS) in an interrupted or simple continuous fashion. The aim is to re-approximate the nail fold to the remaining nail plate, thereby narrowing the nail sulcus and reducing the potential for impingement.
7. Dressing: As described above.

B. Zadek Procedure (Total Proximal Matrix Excision):
Less commonly employed for isolated onychocryptosis, this procedure involves the complete excision of the entire proximal nail fold and underlying matrix, resulting in complete and permanent nail plate ablation. It is generally reserved for severe, diffuse nail dystrophies (e.g., onychogryphosis, severe onychomycosis unresponsive to medical treatment) or intractable recurrent onychocryptosis involving the entire nail plate where complete removal is desired, or in cases of intractable chronic paronychia where the entire nail matrix is diseased. This results in a permanent nail-less digit.

1. Anesthesia and Tourniquet: As described above.
2. Incision: Using a No. 15 scalpel blade, a transverse elliptical or "W"-shaped incision is made at the base of the proximal nail fold. The distal limb of the incision is typically at the level of the lunula, and the proximal limb extends slightly proximal to the nail matrix, encompassing all germinal tissue.
3. Flap Elevation and Nail Avulsion: The entire nail plate is typically totally avulsed at this stage. The proximal nail fold is sharply dissected and elevated as a flap, carefully exposing the entire germinal matrix underneath.
4. Matrix Excision: The entire germinal matrix is meticulously dissected and excised from the underlying periosteum of the distal phalanx using a scalpel. All matrix remnants must be identified and removed to prevent regrowth of nail spicules or an entire deformed nail plate. The nail bed is often included in the excision, leaving the periosteum exposed.
5. Closure: The proximal nail fold flap is then re-draped and secured to the nail bed or underlying fibrous tissue with fine sutures to create a smooth, nail-less digit.
6. Dressing: As described above.

Internervous Planes, Reduction, and Fixation:

For onychocryptosis surgery, the terms "internervous planes," "reduction," and "fixation" are not applicable in their traditional orthopedic context of skeletal surgery or joint reconstruction.
* Internervous Planes: While a thorough understanding of digital nerve anatomy is crucial for effective nerve blocks and to prevent iatrogenic nerve injury during more extensive excisions (e.g., Winograd, Zadek), surgical dissection in onychocryptosis typically remains superficial to major neurovascular bundles, focusing on the epidermal and dermal layers of the nail unit and the nail matrix. The primary objective is to separate the nail plate from the nail bed, and the matrix from the underlying periosteum, operating within soft tissue planes.
* Reduction: There is no "reduction" of a fracture or dislocation in onychocryptosis surgery. Metaphorically, "reduction" could refer to the permanent reduction of the nail plate width or the lateral nail fold hypertrophy and inflammatory tissue, achieved by matrix ablation/excision.
* Fixation: No bony or joint structures are primarily involved or require fixation. The goal is permanent destruction or removal of the offending matrix cells, which is achieved through chemical or surgical ablation, not physical fixation with hardware.

Complications & Management

While generally safe and highly effective, surgical procedures for onychocryptosis, like all interventions, carry potential risks and complications. Academic orthopedic surgeons must be adept at identifying, preventing, and managing these complications to ensure optimal patient outcomes and functional preservation.

Common Complications, Incidence, and Salvage Strategies:

| Complication | Approximate Incidence (Varies by technique and surgeon experience) | Management / Salvage Strategies |

Post-Operative Rehabilitation Protocols

Post-operative rehabilitation is critical for optimizing wound healing, minimizing complications, and facilitating a swift return to full function. The protocols are generally straightforward and largely patient-driven.

Immediate Post-Operative Phase (Days 0-3):

• Elevation: Instruct the patient to keep the affected foot elevated above heart level as much as possible, particularly for the first 24-48 hours. This significantly reduces post-operative edema, pain, and throbbing.
• Analgesia: Prescribe or recommend appropriate oral analgesics (e.g., NSAIDs, acetaminophen, or a short course of opioid analgesics if necessary for severe pain). Advise patients to take medication as scheduled rather than waiting for pain to become severe.
• Dressing Care: The initial bulky dressing should remain intact and dry for the first 24-48 hours. Patients are instructed to keep the foot dry and avoid showering during this period.
• Activity: Rest is generally recommended. Ambulation should be limited to essential activities (e.g., restroom trips) for the first day, with a gradual increase thereafter as tolerated. Patients should wear loose-fitting, open-toed footwear (e.g., sandals) to avoid pressure on the surgical site.

Early Post-Operative Phase (Day 3 to Week 2):

• Dressing Changes: The initial dressing is typically removed after 24-48 hours. Patients are instructed on sterile daily dressing changes. This usually involves:
  • Soaking the toe in warm saline (or plain warm water) for 10-15 minutes, 2-3 times daily, to facilitate wound cleansing and aid in the removal of necrotic debris (especially important after phenolization).
  • Gently drying the toe.
  • Applying a small amount of topical antibiotic ointment (e.g., bacitracin, mupirocin) or petroleum jelly.
  • Applying a clean, non-adherent dressing (e.g., Telfa, petrolatum gauze) and securing it with a small amount of gauze and paper tape or a light wrap.
• Hygiene: Gentle showering is permitted, but the toe should be kept dry after soaking or showering. Avoid harsh soaps or scrubbing the wound.
• Footwear: Continue wearing loose-fitting, open-toed shoes. Avoid tight-fitting footwear or activities that put direct pressure on the toe.
• Activity: Gradual increase in ambulation and light daily activities as tolerated. Avoid strenuous exercise, prolonged standing, or heavy lifting.
• Monitoring for Infection: Educate patients to monitor for signs of infection (increased redness, swelling, purulent drainage, fever, escalating pain) and to contact the surgical team promptly if these occur.

Intermediate Post-Operative Phase (Week 2 to Week 6):

• Wound Healing: The wound (especially after phenolization) will typically continue to drain serosanguineous fluid for 2-4 weeks. This prolonged drainage is a characteristic effect of phenol-induced necrosis and should not necessarily be interpreted as infection unless other signs are present. The treated area will gradually re-epithelialize.
• Dressing Frequency: As drainage decreases and the wound heals, the frequency of dressing changes can be reduced (e.g., once daily, then every other day).
• Footwear Transition: Patients can gradually transition back to normal, well-fitting closed-toe shoes once the wound is dry and comfortable. Emphasize wearing shoes with an adequate toe box.
• Activity: Gradual return to more strenuous activities, including sports, as pain permits and the wound is fully epithelialized.
• Nail Regrowth (if applicable): If partial nail avulsion without matricectomy was performed, monitor for normal nail regrowth and reinforce proper nail trimming techniques. If matricectomy was performed, monitor for any signs of aberrant nail regrowth (e.g., spicule).

Long-Term Monitoring & Prevention:

• Follow-up: Scheduled post-operative visits are typically at 1-2 weeks for wound check, and then at 6-8 weeks or longer to assess definitive healing, recurrence, and cosmetic outcome.
• Nail Care Education: Crucial for preventing recurrence in other nails or if the initial matricectomy was incomplete. Emphasize:
  • Cutting toenails straight across, not rounding the corners.
  • Not cutting nails too short.
  • Using clean, sharp nail clippers.
  • Avoiding picking at nails or cuticles.
• Footwear Advice: Counsel patients on the importance of wearing properly fitting shoes with an adequate toe box that do not compress the toes.
• Diabetic/Neuropathic Patients: Reinforce meticulous daily foot inspection, proper wound care, and prompt reporting of any skin changes or irritation. These patients require closer follow-up.

Summary of Key Literature / Guidelines

The literature on onychocryptosis management is extensive, with numerous studies comparing conservative and various surgical techniques. Key themes and consensus points emerge regarding efficacy, recurrence rates, and complication profiles.

Evidence-Based Recommendations:

1. Conservative Management: For mild, acute, or first-episode onychocryptosis without infection or significant granulation tissue, conservative measures are the initial recommended approach. A meta-analysis by Eekhof et al. (1999) and subsequent systematic reviews consistently highlight the importance of proper nail trimming, appropriate footwear, and regular foot hygiene. However, conservative failure rates are high in chronic or recurrent cases.
2. Partial Nail Avulsion Alone: Simple partial nail avulsion without matricectomy, while providing immediate symptomatic relief, has notoriously high recurrence rates (ranging from 30% to 70%). It is generally discouraged as a definitive treatment for recurrent onychocryptosis. It may be considered for acute infection drainage or temporary relief in specific contexts, but patients should be counselled regarding high recurrence risk.
3. Matricectomy Techniques as Gold Standard: For definitive management of recurrent or severe onychocryptosis, procedures incorporating matricectomy (permanent ablation of the offending nail matrix) are widely supported as the treatment of choice.
   • Chemical Matricectomy (Phenolization): Numerous studies, including systematic reviews and meta-analyses, confirm that partial nail avulsion with chemical matricectomy, particularly using 88% or 90% phenol, offers the highest success rates (typically 90-95% recurrence-free) with a favorable complication profile. Key studies by Bostanci et al. (2009), Mogensen et al. (2014), and a Cochrane review by round et al. (2018) underscore its superior efficacy over simple avulsion or surgical excisional techniques for recurrence prevention. The primary complications are often prolonged drainage and mild chemical burns if not carefully applied.
   • Surgical Matricectomy (e.g., Winograd, Zadek): Surgical excisional techniques, such as the Winograd partial matrix excision, also demonstrate high success rates (85-95%) and are particularly valuable when significant hypertrophy of the lateral nail fold needs to be resected, or when chemical agents are contraindicated. However, they are more invasive, carry higher risks of post-operative pain, infection, and potential for nail deformity (e.g., wide scar, lateral spike) if not meticulously performed. The Zadek procedure, leading to total nail ablation, is reserved for severe nail pathologies and carries significant morbidity for the patient seeking a cosmetically intact digit.
4. Comparison of Techniques: A meta-analysis by Piraccini and Pironi (2018) highlighted that phenol matricectomy generally has lower recurrence rates than surgical matricectomy, potentially due to better destruction of microscopic matrix remnants. However, both are significantly more effective than simple avulsion.
5. Role of Antibiotics: Prophylactic antibiotics are generally not indicated for uncomplicated surgical management of onychocryptosis. However, a short course of oral antibiotics is recommended pre-operatively if active cellulitis or purulent infection is present, especially in high-risk patients (diabetics, immunocompromised). Post-operatively, antibiotics are reserved for documented infection.
6. Granulation Tissue Management: Excision of hypertrophic granulation tissue significantly improves outcomes and access to the matrix. Some studies suggest silver nitrate or topical corticosteroids can reduce granulation tissue, but surgical excision is definitive during matricectomy.

Professional Guidelines:

• American Academy of Orthopaedic Surgeons (AAOS): While specific, detailed guidelines solely for onychocryptosis from AAOS are limited, the principles of addressing underlying deformity, minimizing recurrence, and prioritizing patient-specific factors (e.g., diabetes) align with general orthopedic surgical tenets. The emphasis is on definitive management for recurrent or complicated cases.
• American College of Foot and Ankle Surgeons (ACFAS): ACFAS regularly publishes clinical practice guidelines that endorse chemical matricectomy as a highly effective and preferred method for permanent correction of onychocryptosis, alongside surgical excisional techniques when indicated. These guidelines underscore the importance of patient selection, meticulous technique, and comprehensive post-operative care.
• Dermatology and Podiatry Societies: Similar consensus exists within dermatological and podiatric professional bodies (e.g., American Academy of Dermatology, various national Podiatry associations), consistently recommending matricectomy procedures for definitive treatment. They often highlight the safety and efficacy of phenolization as a first-line permanent surgical approach.

Future Directions:

Research continues to explore novel techniques, such as CO2 laser matricectomy, radiofrequency ablation, and specialized nail bracing systems for pincer nails. However, these techniques often present varied success rates, higher equipment costs, or more specialized training requirements compared to the established efficacy of phenol matricectomy. The current body of literature firmly supports the role of matricectomy as the definitive surgical approach for recurrent or complicated onychocryptosis, with phenolization typically favored for its efficacy and minimally invasive nature. Careful patient selection and meticulous surgical technique remain paramount for achieving successful, long-term outcomes.